riociguat
Selected indexed studies
- Riociguat. (, 2006) [PMID:34699155]
- Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. (N Engl J Med, 2013) [PMID:23883377]
- Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study. (Lancet Respir Med, 2019) [PMID:31416769]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Riociguat. (2006) pubmed
- Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. (2013) pubmed
- Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study. (2019) pubmed
- Riociguat for the treatment of pulmonary arterial hypertension. (2013) pubmed
- Riociguat. (2012) pubmed
- Riociguat in the Treatment of Pulmonary Arterial Hypertension. (2022) pubmed
- Riociguat: Clinical research and evolving role in therapy. (2021) pubmed
- Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study. (2022) pubmed
- Overview of Riociguat and Its Role in the Treatment of Pulmonary Hypertension. (2022) pubmed
- Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial. (2021) pubmed